CCCC Institutional Ownership & Shareholders

C4 THERAPEUTICS INC (CCCC) is currently held by 147 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $545.13M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.

Morgan Stanley is currently the largest disclosed institutional shareholder of CCCC tracked by InsiderSet, reporting ownership valued at approximately $41.41M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $28.46M, representing an estimated loss of -31.26% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 54% of the total disclosed CCCC value among the investors covered in this analysis. Major shareholders include Morgan Stanley, Ra Capital Management, L.P., Blackrock, Inc., and several other long-term asset managers with concentrated positions in C4 THERAPEUTICS INC (CCCC).

This page ranks the largest institutional CCCC shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

147

Total Reported Value

$545.13M

Largest Holder

Morgan Stanley

Largest Position

$41.41M

Insider Transactions (90d)

4

Latest Filing Quarter

Q2 2026

New Institutional Positions

135

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Morgan Stanley0.00%8,867,338$41,410,468$28,464,155-$12,946,313-31.26%
Ra Capital Management, L.P.0.32%8,000,000$37,360,000$25,680,000-$11,680,000-31.26%
Blackrock, Inc.0.00%7,896,718$36,877,672$25,348,465-$11,529,207-31.26%
Lynx1 Capital Management Lp3.95%7,326,691$34,215,647$23,518,678-$10,696,969-31.26%
Squadron Capital Management Llc11.51%7,200,000$33,624,000$23,112,000-$10,512,000-31.26%
Bain Capital Life Sciences Investors, Llc1.99%7,171,910$33,492,820$23,021,831-$10,470,989-31.26%
Jpmorgan Chase & Co0.00%4,747,424$20,651,295$15,239,231-$5,412,064-26.21%
Vanguard Capital Management Llc0.00%4,417,731$20,630,804$14,180,917-$6,449,887-31.26%
Citadel Advisors Llc0.01%4,187,580$19,555,999$13,442,132-$6,113,867-31.26%
Goldman Sachs Group Inc0.00%3,530,991$16,489,728$11,334,481-$5,155,247-31.26%
Two Sigma Investments, Lp0.01%3,469,707$16,203,532$11,137,759-$5,065,773-31.26%
Soleus Capital Management, L.P.0.54%3,377,981$15,775,171$10,843,319-$4,931,852-31.26%
Silverarc Capital Management, Llc1.58%3,032,060$14,159,720$9,732,913-$4,426,807-31.26%
Wasatch Advisors Lp0.10%4,160,048$13,852,960$13,353,754-$499,206-3.60%
Bank Of America Corp0.00%2,656,359$12,405,197$8,526,912-$3,878,285-31.26%
Geode Capital Management, Llc0.00%2,522,163$11,780,697$8,096,143-$3,684,554-31.28%
Ikarian Capital, Llc1.86%2,433,000$11,362,110$7,809,930-$3,552,180-31.26%
State Street Corp0.00%2,115,621$9,879,950$6,791,143-$3,088,807-31.26%
Acadian Asset Management Llc0.01%1,806,199$8,429,000$5,797,899-$2,631,101-31.21%
Candriam S.C.A.0.04%1,796,937$8,383,622$5,768,168-$2,615,454-31.20%
D. E. Shaw & Co., Inc.0.01%1,740,989$8,130,419$5,588,575-$2,541,844-31.26%
Susquehanna International Group, Llp0.01%1,732,210$8,089,421$5,560,394-$2,529,027-31.26%
Patient Square Capital Lp1.16%1,608,815$7,513,166$5,164,296-$2,348,870-31.26%
Highvista Strategies Llc1.44%1,348,136$6,295,800$4,327,517-$1,968,283-31.26%
Renaissance Technologies LLCJim Simons0.01%1,189,828$5,556,497$3,819,348-$1,737,149-31.26%
Dimensional Fund Advisors Lp0.00%1,188,507$5,546,166$3,815,107-$1,731,059-31.21%
Northern Trust Corp0.00%1,160,547$5,419,754$3,725,356-$1,694,398-31.26%
Congress Asset Management Co0.03%1,256,692$4,184,784$4,033,981-$150,803-3.60%
Fmr Llc0.00%894,054$4,175,231$2,869,913-$1,305,318-31.26%
Ubs Group Ag0.00%828,970$3,871,289$2,660,994-$1,210,295-31.26%
Charles Schwab Investment Management Inc0.00%781,060$3,647,550$2,507,203-$1,140,347-31.26%
Boothbay Fund Management, Llc0.06%736,331$3,438,666$2,363,623-$1,075,043-31.26%
Vanguard Portfolio Management Llc0.00%680,094$3,176,039$2,183,102-$992,937-31.26%
Vanguard Fiduciary Trust Co0.00%609,146$2,844,712$1,955,359-$889,353-31.26%
Exoduspoint Capital Management, Lp0.03%580,195$2,709,511$1,862,426-$847,085-31.26%
Velan Capital Investment Management Lp1.63%570,000$2,661,900$1,829,700-$832,200-31.26%
Stempoint Capital Lp0.42%523,648$2,445,436$1,680,910-$764,526-31.26%
Rockefeller Capital Management L.P.0.00%495,817$2,315,465$1,591,573-$723,892-31.26%
Nuveen, Llc0.00%484,010$2,260,326$1,553,672-$706,654-31.26%
Wells Fargo & Company/Mn0.00%452,701$2,114,113$1,453,170-$660,943-31.26%
Man Group Plc0.00%408,648$1,908,386$1,311,760-$596,626-31.26%
Platinum Investment Management Ltd0.44%384,766$1,796,857$1,235,099-$561,758-31.26%
Seven Fleet Capital Management Lp0.29%381,169$1,780,059$1,223,552-$556,507-31.26%
Qube Research & Technologies Ltd0.00%370,554$1,730,487$1,189,478-$541,009-31.26%
Atom Investors Lp0.15%364,351$1,701,519$1,169,567-$531,952-31.26%
Susquehanna Portfolio Strategies, Llc0.02%335,079$1,564,819$1,075,604-$489,215-31.26%
Adage Capital Partners Gp, L.L.C.0.00%325,000$1,517,750$1,043,250-$474,500-31.26%
Jane Street Group, Llc0.00%302,750$1,413,843$971,828-$442,016-31.26%
Connor, Clark & Lunn Investment Management Ltd.0.00%300,734$1,404,428$965,356-$439,072-31.26%
Adar1 Capital Management, Llc0.06%291,957$1,363,439$937,182-$426,257-31.26%
Showing 50 of 149

Frequently asked questions about CCCC

  • Who are the largest institutional holders of CCCC?

    The largest institutional holders of CCCC reported in the latest SEC Form 13F filings include Morgan Stanley, Ra Capital Management, L.P., Blackrock, Inc., Lynx1 Capital Management Lp, and Squadron Capital Management Llc. InsiderSet ranks institutional holders by their latest reported CCCC position.

  • What is CCCC institutional ownership?

    This page tracks CCCC positions reported by institutional investment managers through SEC Form 13F. C4 THERAPEUTICS INC (CCCC) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.

  • How many institutions own CCCC?

    InsiderSet currently tracks 147 institutional managers reporting CCCC holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of CCCC shareholders.

  • How much CCCC stock do institutions own?

    Institutional investment managers disclosed approximately $545.13M in CCCC holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.

  • When was CCCC institutional ownership last updated?

    The latest CCCC institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.

  • Are institutional CCCC holdings real-time?

    No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its CCCC position after the reporting date.

  • Are institutions buying or selling CCCC?

    Institutional buying and selling can be analyzed by comparing CCCC positions across consecutive 13F reporting periods. InsiderSet's CCCC Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View CCCC ownership changes.

  • How has CCCC institutional ownership changed over time?

    InsiderSet tracks CCCC institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.